These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33248967)

  • 1. CMR in Evaluating Valvular Heart Disease: Diagnosis, Severity, and Outcomes.
    Myerson SG
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):2020-2032. PubMed ID: 33248967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cardiac valvular regurgitant lesions by cardiac MRI sequences: comparison of a four-valve semi-quantitative versus quantitative approach.
    Reddy ST; Shah M; Doyle M; Thompson DV; Williams RB; Yamrozik J; Biederman RW
    J Heart Valve Dis; 2013 Jul; 22(4):491-9. PubMed ID: 24224411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review.
    Gorecka M; Bissell MM; Higgins DM; Garg P; Plein S; Greenwood JP
    J Cardiovasc Magn Reson; 2022 Aug; 24(1):49. PubMed ID: 35989320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cardiovascular magnetic resonance in the evaluation of valve disease.
    Karamitsos TD; Myerson SG
    Prog Cardiovasc Dis; 2011; 54(3):276-86. PubMed ID: 22014494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management.
    Mathew RC; Löffler AI; Salerno M
    Curr Cardiol Rep; 2018 Sep; 20(11):119. PubMed ID: 30259253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cardiac magnetic resonance in valvular heart disease.
    Lopez-Mattei JC; Shah DJ
    Methodist Debakey Cardiovasc J; 2013; 9(3):142-8. PubMed ID: 24066197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart valve disease: investigation by cardiovascular magnetic resonance.
    Myerson SG
    J Cardiovasc Magn Reson; 2012 Jan; 14(1):7. PubMed ID: 22260363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance in the evaluation of heart valve disease.
    Gulsin GS; Singh A; McCann GP
    BMC Med Imaging; 2017 Dec; 17(1):67. PubMed ID: 29284450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Magnetic Resonance in Valvular Heart Disease: Assessment of Severity and Myocardial Remodeling.
    Malahfji M; Shah DJ
    Methodist Debakey Cardiovasc J; 2020; 16(2):106-113. PubMed ID: 32670470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional valve assessment: the emerging role of cardiovascular magnetic resonance.
    Shah DJ
    Methodist Debakey Cardiovasc J; 2010; 6(1):15-9. PubMed ID: 20360653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality imaging in bicuspid aortic valve.
    Galian-Gay L; Rodríguez-Palomares J; Guala A; Michelena HI; Evangelista A
    Prog Cardiovasc Dis; 2020; 63(4):442-451. PubMed ID: 32531300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac magnetic resonance imaging in valvular heart disease.
    Koskenvuo JW; Järvinen V; Pärkkä JP; Kiviniemi TO; Hartiala JJ
    Clin Physiol Funct Imaging; 2009 Jul; 29(4):229-40. PubMed ID: 19302226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular global longitudinal strain in bicupsid aortic valve patients: head-to-head comparison between computed tomography, 4D flow cardiovascular magnetic resonance and speckle-tracking echocardiography.
    van den Hoven AT; Yilmazer S; Chelu RG; van Grootel RWJ; Minderhoud SCS; Bons LR; van Berendoncks AM; Duijnhouwer AL; Siebelink HJ; van den Bosch AE; Budde RPJ; Roos-Hesselink JW; Hirsch A
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1771-1780. PubMed ID: 32451876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valvular heart disease: assessment of valve morphology and quantification using MR.
    Schwitter J
    Herz; 2000 Jun; 25(4):342-55. PubMed ID: 10948771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Consistency Assessment of Valvular Flow Quantification With Automated Valve Tracking in 4D Flow CMR.
    Juffermans JF; Minderhoud SCS; Wittgren J; Kilburg A; Ese A; Fidock B; Zheng YC; Zhang JM; Blanken CPS; Lamb HJ; Goeman JJ; Carlsson M; Zhao S; Planken RN; van Ooij P; Zhong L; Chen X; Garg P; Emrich T; Hirsch A; Töger J; Westenberg JJM
    JACC Cardiovasc Imaging; 2021 Jul; 14(7):1354-1366. PubMed ID: 33582060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of valvular disease by cardiac computed tomography assessment.
    Buttan AK; Yang EH; Budoff MJ; Vorobiof G
    J Cardiovasc Comput Tomogr; 2012; 6(6):381-92. PubMed ID: 23217461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features of carcinoid heart disease identified by cardiac computed tomography.
    Davar J; Lazoura O; Caplin ME; Toumpanakis C
    J Cardiovasc Comput Tomogr; 2021; 15(2):167-174. PubMed ID: 33004299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology of congenital and acquired aortic valve disease by cardiovascular magnetic resonance imaging.
    Looi JL; Kerr AJ; Gabriel R
    Eur J Radiol; 2015 Nov; 84(11):2144-54. PubMed ID: 26255206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and quantification of valvular heart disease with dynamic cardiac MR imaging.
    Didier D; Ratib O; Lerch R; Friedli B
    Radiographics; 2000; 20(5):1279-99; discussion 1299-301. PubMed ID: 10992018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular regurgitation: does cardiovascular magnetic resonance provide additional information compared to echocardiography?
    Cawley PJ; Otto CM
    Minerva Cardioangiol; 2009 Aug; 57(4):521-35. PubMed ID: 19763073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.